Introduction
Coumarin derivatives are preeminent amongst the heterocyclic scaffolds found in both naturally occurring products as well as in designed medicinal agents. They possess many biological activities varying from anticancer, 1 anti-HIV, 2,3 anti-Alzheimer, 4,5 antiviral, 6 antimicrobial, 7, 8 antioxidant, 9 anti-inflammatory, 10 antituberculosis, 11 anti-influenza, 12 and antihyperlipidemic. 13, 14 Moreover, Warfarin is a 4-hydroxycoumarin derivative that has been used as an anticoagulant drug for a long time. In addition, scopoletin 15 and esculatin 16 were found in nature and they have antiproliferative, antioxidant, and anti-inflammatory activities ( Figure 1 ). Dihydrofurocoumarins such as fercoprolone, 17 mutisicoumarin, 18 cyclobrachycoumarin, 19 and isoerlengefusciol 20 have been found in nature and they have similar activities to coumarin derivatives. We have also recently reported that some 3-cyano-4,5-dihydrofurans show antifungal and antibacterial activities. 21 Lunacrine, bucharaminol, acrophylline, dicramnine, isotaifine, araliopsine, almein, and oligophylidine are quinoline alkaloids commonly found in nature. It is reported that these compounds show antiparasitic, anthelmintic, cytotoxic, antiarrhythmic, spasmolytic, sedative, antitumor, and antimalarial activities.
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Although there are some antifungal drugs clinically used in the treatment of fungal infections, there is always a need for new antifungal agents due to the low efficacy, side effects, or resistance associated with the existing drugs. Thus, the growing demand for coumarin derivatives increases the need for developing new methods in this area. Several methods for preparation of dihydrofurocoumarins have been developed in the last three decades. These include cyclization of 4-hydroxycoumarin and 4-hydroxy-2-quinoline with iodides and allene via palladium catalyses. 28 33, 42, 43 have been used as radical oxidants in the synthesis of dihydrofuran derivatives forming a C-C bond between active methylene compounds and alkenes. Previously, we described the formation of some dihydrofurocoumarin derivatives from the reaction of 4-hydroxycoumarin and alkenes mediated by Mn(OAc) 3 .
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In the present study, we performed the reaction of 4-hydroxycoumarin and 4-hydroxyquinoline with conjugated dienes promoted by CAN leading for ethenyl substituted 2,3-dihydrofurocoumarin in moderate to good yields. We also investigated the antifungal activity of these compounds against C. albicans, C. parapsilosis, C. krusei, C. glabrata, C. tropicalis and Aspergillus fumigatus. Furthermore, 1,1-diphenyl-1,3-butadiene (2b) was synthesized from the water elimination of 1,1-diphenylbut-3-en-1-ol compound obtained from the Grignard reaction of allylmagnesium bromide with benzophenone.
Results and discussion
1-Phenyl-1,3-butadiene (2a), 44 3-methyl-1-phenyl-1,3-butadiene (2c), 45 (E) -2-(buta-1,3-dien-1-yl)thiophene
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As seen in Table 1 , the reactions of 4-hydroxycoumarin 1a with 1-phenyl-1,3-butadiene 2a and 1,1-diphenyl-1,3-butadiene 2b gave 2,3-dihydrofurocoumarins 3a (65%) and 3b (83%) in good yields, respectively. Moreover, we obtained similar results from the reaction of 3-methyl-1-phenyl-1,3-butadiene 2c with 1a to form dihydrofurocoumarin 3c in 78% yield. Additionally, the treatment of 1a with 1,3-diphenyl-1,3-butadiene 2d formed dihydrofurans 3d in 70% yield. Compounds 3e (46%) and 3f (36%) were obtained from the radical cyclization of 1a with 1-(2-thienyl)-1,3-butadiene 2e and 3-methyl-1-(2-thienyl)-1,3-butadiene 2f, respectively.
Similarly, 4-hydroxyquinoline 1b with 2a and 2d formed 3,5-dihydrofuroquinolines 3g (42%) and 3h (62%) in moderate yields. The proposed mechanism for the radical cyclization of 4-hydroxycoumarin and 4-hydroxyquinoline with conjugated dienes mediated by CAN leading to formation of 2,3-dihydrofurocoumarin and 3,5-dihydrofuroquinoline is displayed in Figure 2 . According to this mechanism, while Ce 4+ is reduced to Ce 3+ , a radical cation (A) is formed as described by Jiao. In conclusion, the radical cyclizations of 4-hydroxycoumarin and 4-hydroxyquinoline with various conjugated dienes mediated by CAN were performed in this study, leading to formation of novel dihydrofurocoumarins (3a-f ) and dihydrofuroquinolines (3g, 3h) in moderate to good yields. Moreover, antifungal activities of these dihydrofurocoumarin and dihydrofuroquinoline derivatives were examined against various Candida species and Aspergillus fumigatus. These compounds show medium antifungal activities since the solubility of the dihydrofurocoumarins and dihydrofuroquinolines is low in the buffer. Thus, studies on the biological activity of similar compounds that are more soluble in buffer medium and further transformation of the dihydrofuran derivatives are in progress.
Experimental
Melting points were determined on a Gallenkamp capillary melting point apparatus. IR spectra (KBr disc, amphotericin B (Sigma-Aldrich), were purchased from the supplying company. The last concentration ranges of all compounds in the wells were between 2.25 µ L and 1000 µ L. The minimum inhibitory concentration (MIC) was the minimum concentration of the compound that showed full inhibition of fungal growth in the well compared to the control well containing only fungal inoculum and culture media. MIC was determined with the naked eye by an experienced mycologist. The antifungal susceptibility test for each species was repeated three times.
Synthesis of 3-methyl-1-(2-thienyl)-1,3-butadiene (2f )
A solution of triphenylmethylphosphonium bromide (42.5 mmol) and sodium hydride (44.6 mmol) in anhydrous THF (75 mL) was stirred in an ice-salt bath for 15 min. Then the reaction mixture was heated at reflux for 2 h. After this time, the 2-acetylthiophene solution (17 mmol) in anhydrous THF was added to the reaction mixture dropwise with cooling and stirring in an ice-salt bath for half an hour. Then the reaction mixture was stirred overnight at room temperature. The THF evaporated and the mixture was extracted with n -hexane (monitored by TLC until product vanished). Combined organic phases were concentrated. The crude product was purified by column chromatography using n-hexane as eluent. 
General procedure for the synthesis of dihydrofurocoumarin and dihidrofuroquinoline compounds (3a-h)
To a solution of 4-hydroxyenone (1 mmol) and diene (1.2 mmol) in THF (15 mL) under N 2 was added a mixture of CAN (2.4 mmol) and NaHCO 3 (2.4 mmol) at 40
• C. The reaction was monitored by TLC and completed when the orange color of CAN had disappeared (10-30 min). H 2 O was added to the solution and the mixture was extracted with CHCl 3 (3 × 20 mL). The combined organic phase was dried (Na 2 SO 4 ) and concentrated and the crude product was purified by column chromatography (silica gel, 230-400 mesh) or preparative TLC (20 × 20 cm plates, 2 mm thickness, hexane/EtOAc 3:1). 
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Antifungal activity test
Antifungal activity was determined against clinically important Candida species (C. albicans, C. tropicalis, C. glabrata, C. krusei, and C. parapsilosis) and Aspergillus fumigatus. The antifungal susceptibility against the tested compounds (3a-h) was determined. Table 2 shows the fluconazole, caspofungin, and amphotericin B susceptibility results as MIC values. According to these values all strains were susceptible to the tested antifungals except C. krusei. C. krusei is known as intrinsically resistant to fluconazole and so the high MIC value (32 µ g/mL) was expected. Table 2 , MIC values obtained with all compounds were between 62.5 and 500 µg/mL.
Compounds 3c and 3d possess the best antifungal activity with MIC values of 62.5 µ g/mL against C. albicans and C. glabrata. The MIC value of compound 3d was 500 µ L/mL for A. fumigatus, which is two times higher than MIC values obtained with other compounds. Therefore, it is possible to conclude that the tested compounds (3a-h) display antifungal activity against both Candida species and A. fumigatus. However, in our study, among the species tested, C. albicans was found to be the most susceptible Candida species against the tested dihydrofurocoumarins.
